iCAD is a leading company in San Jose, CA that specializes in AI-powered solutions for cancer detection, with a particular focus on breast health. Their ProFound Breast Health Suite offers a range of solutions including Detection, Density Assessment, Risk Evaluation, and soon-to-be-released Heart Health assessment. With their clinically proven AI algorithms, iCAD aims to expose where cancer may be hiding and predict when it might make its move, ultimately improving patient outcomes and saving lives.
With over 25 years of experience, iCAD has made significant advancements in the field of cancer detection, with their solutions available in over 50 countries. They have been granted 45 patents and have conducted 51 clinical studies, training their algorithms on over 6 million images. iCAD's technology has been FDA cleared, CE marked, and Health Canada licensed, making it a trusted and reliable option for healthcare providers worldwide.
Generated from the website